A first-in-patient trial using AAV-based OTOF gene therapy, led by Karolinska Institutet and Chinese hospitals, restored hearing (improving from 106 dB to 52 dB) in 10 individuals aged 1–24.
Amidst the rising spread of antimicrobial resistance, hope emerges in the form of a ground-breaking tool. Progress in gene editing holds the potential to curb the relentless march of antimicrobial resistance.
The secret of the genetic risk of schizophrenia has been hiding in plain sight — the placenta, says the groundbreaking study conducted by the Lieber Institute for Brain Development.
The number of people contracting autoimmune diorders in the United Kingdom is growing, including diseases like type 1 diabetes and rheumatoid arthritis. But why?
A universal receptor system that enables T cells to recognize any cell surface target has been created by University of Pittsburgh researchers, which could revolutionise customizable immunotherapies for treating cancer and other diseases.
Chronic wounds continue to cause problems for both elderly and diabetic patients, however, using electric stimulation, new research promises to speed up the healing process by up to three times.
Researchers were able to better identify the causes of endometriosis using different datasets of women with and without the condition, finding genetics play a large role.
Researchers uncover ancient Siberian genomes which reveal a previously undescribed group of early hunter-gatherer population in Neolithic Altai-Sayan region.
Craig Caceci, Managing Director, Terebellum®, walks us through how to overcome the cost challenge of CGT development for rare, orphan and genetic therapies.
Dr Stacey Lockyer, Senior Nutrition Scientist at the British Nutrition Foundation, walks us through understanding diabetes & reducing the risk of type 2 diabetes.
